ATRA logo

Atara Biotherapeutics (ATRA) Depreciation And Amortization

Annual D&A

$4.83 M
-$824.00 K-14.58%

December 31, 2023

Summary

Performance

1-Year Change

-14.58%

3-Year Change

-42.04%

5-Year Change

+29.39%

15-Year Change

+405.13%

ATRA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.89%
ATRA annual depreciation & amortization is higher than 62.89% of companies in Healthcare sector

High & Low

All-time High

$9.35 M
ATRA annual depreciation & amortization is currently -48.33% below its historical high of $9.35 million

3-Year Low

$4.83 M
ATRA annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ATRA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
ATRA next annual earnings announcement is scheduled for Mar 28, 2025

Related metrics

Annual Total Expenses

$284.58 M
ATRA annual total expenses is $284.58 million

Annual Operating Expenses

$275.69 M
ATRA annual total operating expenses is $275.69 million

Annual Cost Of Goods Sold

$8.89 M
ATRA annual cost of goods sold is $8.89 million

Annual Interest Expense

$5.29 M
ATRA annual interest expense is $5.29 million

Quarterly D&A

$1.23 M
-$100.00 K-7.52%

September 30, 2024

Summary

Performance

3-Month Change

-7.52%

1-Year Change

+2.07%

3-Year Change

+2.41%

5-Year Change

+2.41%

ATRA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.76%
ATRA quarterly depreciation & amortization is higher than 61.76% of companies in Healthcare sector

High & Low

All-time High

$2.49 M
ATRA quarterly depreciation & amortization is currently -50.56% below its historical high of $2.49 million

3-Year Low

$1.20 M
ATRA quarterly depreciation & amortization is currently +2.41% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ATRA next earnings announcement is scheduled for Mar 28, 2025

Related metrics

Quarterly Total Expenses

$61.95 M
ATRA quarterly total expenses is $61.95 million

Quarterly Operating Expenses

$54.34 M
ATRA quarterly total operating expenses is $54.34 million

Quarterly Cost Of Goods Sold

$7.60 M
ATRA quarterly cost of goods sold is $7.60 million

Quarterly Interest Expense

$1.18 M
ATRA quarterly interest expense is $1.18 million

TTM D&A

$5.16 M
+$21.00 K+0.41%

September 30, 2024

Summary

Performance

3-Month Change

+0.41%

1-Year Change

+6.77%

3-Year Change

+2.32%

5-Year Change

+2.32%

ATRA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

61.94%
ATRA TTM depreciation & amortization is higher than 61.94% of companies in Healthcare sector

High & Low

All-time High

$9.35 M
ATRA TTM depreciation & amortization is currently -44.83% below its historical high of $9.35 million

3-Year Low

$4.83 M
ATRA TTM depreciation & amortization is currently +6.77% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ATRA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
ATRA next earnings announcement is scheduled for Mar 28, 2025

Related metrics

Annual Total Expenses

$284.58 M
ATRA annual total expenses is $284.58 million

Annual Operating Expenses

$275.69 M
ATRA annual total operating expenses is $275.69 million

TTM Cost Of Goods Sold

$17.37 M
ATRA TTM cost of goods sold is $17.37 million

TTM Interest Expense

$4.77 M
ATRA TTM interest expense is $4.77 million

ATRA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-14.6%+2.1%+6.8%
3 y3 years-42.0%+2.4%+2.3%
5 y5 years+29.4%+2.4%+2.3%

ATRA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.3%at low-50.6%+2.4%-44.8%+6.8%
5 y5-year-48.3%at low-50.6%+2.4%-44.8%+6.8%
alltimeall time-48.3%>+9999.0%-50.6%>+9999.0%-44.8%>+9999.0%

Atara Biotherapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.23 M(-7.5%)
$5.16 M(+0.4%)
Jun 2024
-
$1.33 M(-4.4%)
$5.13 M(+2.6%)
Mar 2024
-
$1.39 M(+15.4%)
$5.01 M(+3.7%)
Dec 2023
$4.83 M(-14.6%)
$1.21 M(-0.3%)
$4.83 M(-1.0%)
Sep 2023
-
$1.21 M(+0.7%)
$4.88 M(-3.2%)
Jun 2023
-
$1.20 M(-1.1%)
$5.04 M(-4.5%)
Mar 2023
-
$1.21 M(-3.3%)
$5.28 M(-6.7%)
Dec 2022
$5.65 M(-39.5%)
$1.25 M(-8.3%)
$5.65 M(-17.9%)
Sep 2022
-
$1.37 M(-4.8%)
$6.89 M(-12.1%)
Jun 2022
-
$1.44 M(-9.6%)
$7.83 M(-10.1%)
Mar 2022
-
$1.59 M(-36.1%)
$8.71 M(-6.8%)
Dec 2021
$9.35 M(+12.2%)
$2.49 M(+7.4%)
$9.35 M(+3.7%)
Sep 2021
-
$2.32 M(-0.0%)
$9.01 M(+1.6%)
Jun 2021
-
$2.32 M(+4.3%)
$8.87 M(+3.1%)
Mar 2021
-
$2.22 M(+3.0%)
$8.61 M(+3.3%)
Dec 2020
$8.33 M(+17.9%)
$2.16 M(-0.7%)
$8.33 M(+3.2%)
Sep 2020
-
$2.17 M(+5.8%)
$8.07 M(+5.0%)
Jun 2020
-
$2.05 M(+5.3%)
$7.69 M(+4.3%)
Mar 2020
-
$1.95 M(+2.8%)
$7.37 M(+4.3%)
Dec 2019
$7.07 M(+89.4%)
$1.90 M(+6.0%)
$7.07 M(+6.3%)
Sep 2019
-
$1.79 M(+3.0%)
$6.65 M(+9.9%)
Jun 2019
-
$1.74 M(+5.4%)
$6.05 M(+19.9%)
Mar 2019
-
$1.65 M(+11.5%)
$5.05 M(+35.2%)
DateAnnualQuarterlyTTM
Dec 2018
$3.73 M(+290.4%)
$1.48 M(+24.2%)
$3.73 M(+47.4%)
Sep 2018
-
$1.19 M(+62.8%)
$2.53 M(+59.0%)
Jun 2018
-
$731.00 K(+119.5%)
$1.59 M(+47.0%)
Mar 2018
-
$333.00 K(+19.8%)
$1.08 M(+13.3%)
Dec 2017
$956.00 K(+149.6%)
$278.00 K(+11.2%)
$956.00 K(+12.3%)
Sep 2017
-
$250.00 K(+12.6%)
$851.00 K(+16.3%)
Jun 2017
-
$222.00 K(+7.8%)
$732.00 K(+27.5%)
Mar 2017
-
$206.00 K(+19.1%)
$574.00 K(+49.9%)
Dec 2016
$383.00 K(+697.9%)
$173.00 K(+32.1%)
$383.00 K(+61.6%)
Sep 2016
-
$131.00 K(+104.7%)
$237.00 K(+104.3%)
Jun 2016
-
$64.00 K(+326.7%)
$116.00 K(+103.5%)
Mar 2016
-
$15.00 K(-44.4%)
$57.00 K(+18.8%)
Dec 2015
$48.00 K(+700.0%)
$27.00 K(+170.0%)
$48.00 K(+108.7%)
Sep 2015
-
$10.00 K(+100.0%)
$23.00 K(+53.3%)
Jun 2015
-
$5000.00(-16.7%)
$15.00 K(+36.4%)
Mar 2015
-
$6000.00(+200.0%)
$11.00 K(+83.3%)
Dec 2014
$6000.00(+50.0%)
$2000.00(0.0%)
$6000.00(+20.0%)
Sep 2014
-
$2000.00(+100.0%)
$5000.00(+25.0%)
Jun 2014
-
$1000.00(0.0%)
$4000.00(0.0%)
Mar 2014
-
$1000.00(0.0%)
$4000.00(0.0%)
Dec 2013
$4000.00
$1000.00(0.0%)
$4000.00(+33.3%)
Sep 2013
-
$1000.00(0.0%)
$3000.00(+50.0%)
Jun 2013
-
$1000.00(0.0%)
$2000.00(+100.0%)
Mar 2013
-
$1000.00
$1000.00

FAQ

  • What is Atara Biotherapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Atara Biotherapeutics?
  • What is Atara Biotherapeutics annual D&A year-on-year change?
  • What is Atara Biotherapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Atara Biotherapeutics?
  • What is Atara Biotherapeutics quarterly D&A year-on-year change?
  • What is Atara Biotherapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Atara Biotherapeutics?
  • What is Atara Biotherapeutics TTM D&A year-on-year change?

What is Atara Biotherapeutics annual depreciation & amortization?

The current annual D&A of ATRA is $4.83 M

What is the all time high annual D&A for Atara Biotherapeutics?

Atara Biotherapeutics all-time high annual depreciation & amortization is $9.35 M

What is Atara Biotherapeutics annual D&A year-on-year change?

Over the past year, ATRA annual depreciation & amortization has changed by -$824.00 K (-14.58%)

What is Atara Biotherapeutics quarterly depreciation & amortization?

The current quarterly D&A of ATRA is $1.23 M

What is the all time high quarterly D&A for Atara Biotherapeutics?

Atara Biotherapeutics all-time high quarterly depreciation & amortization is $2.49 M

What is Atara Biotherapeutics quarterly D&A year-on-year change?

Over the past year, ATRA quarterly depreciation & amortization has changed by +$25.00 K (+2.07%)

What is Atara Biotherapeutics TTM depreciation & amortization?

The current TTM D&A of ATRA is $5.16 M

What is the all time high TTM D&A for Atara Biotherapeutics?

Atara Biotherapeutics all-time high TTM depreciation & amortization is $9.35 M

What is Atara Biotherapeutics TTM D&A year-on-year change?

Over the past year, ATRA TTM depreciation & amortization has changed by +$327.00 K (+6.77%)